The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from GlobeNewswire (a Nasdaq OMX company)

Balchem Corporation Announces Quarterly Conference Call for First Quarter 2012 Financial Results on May 2, 2012

Tuesday, April 17, 2012

Balchem Corporation Announces Quarterly Conference Call for First Quarter 2012 Financial Results on May 2, 201212:30 EDT Tuesday, April 17, 2012NEW HAMPTON, N.Y., April 17, 2012 (GLOBE NEWSWIRE) -- Balchem Corporation (Nasdaq:BCPC) today announced that a conference call will be held on Wednesday, May 2, 2012 at 11:00 AM Eastern Time (ET) to review first quarter 2012 results. Dino A. Rossi, Chairman, President and CEO, and Frank Fitzpatrick, Chief Financial Officer, will host the call. Quarterly results will be released to the market on Wednesday, May 2, 2012 at 9:30 AM (ET). The press release, and its accompanying financial exhibits, will also be available on the Company website,, prior to the conference call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for digital replay through Wednesday, May 16, 2012. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use account #298 and replay ID #392863. Both account and replay ID numbers are required for replay access.About Balchem Corporation Balchem Corporation consists of three business segments: ARC Specialty Products; Food, Pharma and Nutrition; and Animal Nutrition and Health. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The Food, Pharma and Nutrition segment provides proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition and Health segment manufactures and supplies products to numerous animal health markets and certain derivative products into industrial applications.CONTACT: Karin McCaffery, Executive Administration Manager Telephone: 845-326-5600 e-mail: